Market Place
Sourcing Support
Celularity Files 10-K, Regains Nasdaq Compliance
01 May 2026 //
FIRSTWORD PHARMA
Celularity Announces Closing of Transaction with NexGel
21 Apr 2026 //
GLOBENEWSWIRE
Celularity Receives Nasdaq Notice For Late Form 10-K Filing
19 Apr 2026 //
FIRSTWORD PHARMA
Celularity Renews NEXGEL Partnership For Biomaterials Franchise
12 Mar 2026 //
GLOBENEWSWIRE
Celularity Secures $35M License Deal To Boost Longevity Strategy
10 Mar 2026 //
GLOBENEWSWIRE
Celularity Gains $12.2M From New Jersey Nol Sale
10 Feb 2026 //
GLOBENEWSWIRE
Celularity CEO Comments on Centers for Medicare Services
26 Dec 2025 //
GLOBENEWSWIRE
Celularity Secures Financing For Strategic Vision
18 Dec 2025 //
GLOBENEWSWIRE
Celularity Partners Defeye For Advancing Regenerative Eye Care
30 Oct 2025 //
GLOBENEWSWIRE
Celularity Gets Nasdaq Notice Over Form 10-Q
22 Aug 2025 //
GLOBENEWSWIRE
Celularity Announces Chief Financial Officer Transition
10 Jun 2025 //
GLOBENEWSWIRE
Celularity Publishes On Tri-Layer Amniotic Membrane For Eye
02 Jun 2025 //
GLOBENEWSWIRE
Celularity Receives Nasdaq Notice Regarding Form 10-Q
30 May 2025 //
GLOBENEWSWIRE
Celularity Announces 2024 Operating and Financial Results
09 May 2025 //
GLOBENEWSWIRE
Celularity Receives Nasdaq Notice Regarding Non-Payment of Fees
25 Apr 2025 //
GLOBENEWSWIRE
Celularity Welcomes CMS Action on Medicare Coverage Determination
14 Apr 2025 //
GLOBENEWSWIRE
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs
27 Jan 2025 //
GLOBENEWSWIRE
Celularity Announces Resolution of Nasdaq Listing Compliance Matter
10 Dec 2024 //
GLOBENEWSWIRE
Celularity Over Sevenfold Growth in Net Product Sales in Q3 2024
06 Dec 2024 //
GLOBENEWSWIRE
Celularity Announces Receipt of Nasdaq Notification
27 Nov 2024 //
GLOBENEWSWIRE
Celularity’s Partner Breaks Ground For Stem Cell Center In APAC
20 Nov 2024 //
GLOBENEWSWIRE
Celularity Announces Resolution of Nasdaq Listing Compliance Matter
18 Nov 2024 //
GLOBENEWSWIRE
Celularity Raises 2024 Guidance, Net Sales Reach $44.4M
07 Nov 2024 //
GLOBENEWSWIRE
Celularity Appeals Nasdaq Compliance Plan
23 Oct 2024 //
GLOBENEWSWIRE
Celularity Provides Corporate Update
22 Oct 2024 //
GLOBENEWSWIRE
Celularity To Present At H.C. Wainwright Investment Conference
05 Sep 2024 //
GLOBENEWSWIRE
Celularity Appoints Richard J. Berman to its Board of Directors
28 Aug 2024 //
GLOBENEWSWIRE
Celularity Reports Strong Sales Growth For 2023 And H1 2024
31 Jul 2024 //
GLOBENEWSWIRE
Celularity`s T-Cell Platform Data In Hematologic, Solid Tumors At ASCO
03 Jun 2024 //
GLOBENEWSWIRE
Celularity Inc. to Host Investor and Analyst Research & Development Day
22 Apr 2024 //
GLOBENEWSWIRE
Celularity Q1 2024 Sales Ahead, SG&A Cuts, Manufacturing Ramp
15 Apr 2024 //
GLOBENEWSWIRE
Celularity Receives HCPCS Q Code Approval from the U.S. Centers
26 Mar 2024 //
GLOBENEWSWIRE
Celularity CEO to Present Keynote Address
12 Mar 2024 //
GLOBENEWSWIRE
Celularity Announces Net Sales Expectations for First Quarter 2024
01 Feb 2024 //
GLOBENEWSWIRE
Celularity Releases CEO Letter to Shareholders
18 Jan 2024 //
GLOBENEWSWIRE
Celularity Announces Total Revenue Expectations for Fourth Quarter 2023
03 Jan 2024 //
GLOBENEWSWIRE
Celularity Announces Biomaterial Products Receive SFDA Product Classification
18 Oct 2023 //
GLOBENEWSWIRE
Celularity Announces Multi-Y Research Collab Services Agreement With Regeneron
29 Aug 2023 //
GLOBENEWSWIRE
Celularity Announces $45 Million Purchase Order
23 May 2023 //
GLOBENEWSWIRE
Celularity Announces Advisory Guidance From Tamer Group Anticipated 2023
10 May 2023 //
GLOBENEWSWIRE
Celularity Announces Agreement with AD Ports for Exclusive Product Distribution
28 Mar 2023 //
GLOBENEWSWIRE
Celularity warns of looming layoffs, spotlights early programs as money runs dry
27 Jan 2023 //
ENDPTS
Celularity Completes Strategic Review of 2023 Initiatives
26 Jan 2023 //
GLOBENEWSWIRE
Celularity and CH Trading Group Announce Territory Distribution Agreement
11 Jan 2023 //
BUSINESSWIRE
Celularity Appoints Paul Graves as Chief Communications Officer
04 Jan 2023 //
GLOBENEWSWIRE
Celularity Presents Preclinical Data on CYNK-101, its Allogeneic at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
Imugene’s onCARlytics combination with Celularity’s placental CYCART-19 T cells
10 Nov 2022 //
GLOBENEWSWIRE
Celularity Promotes Two Executives in Executive Leadership Team
06 Oct 2022 //
GLOBENEWSWIRE
Celularity to Present at Jefferies Cell and Genetic Medicine Summit
27 Sep 2022 //
GLOBENEWSWIRE
Celularity Publishes New Data in Frontiers in Immunology Placental (CYNK)
26 Sep 2022 //
GLOBENEWSWIRE
Celularity Enters Into $150 Million Pre-Paid Advance Agreement with Yorkville
15 Sep 2022 //
GLOBENEWSWIRE
Celularity Announces Participation in Upcoming Investor Conferences
06 Sep 2022 //
GLOBENEWSWIRE
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
09 Aug 2022 //
GLOBENEWSWIRE
Celularity To Be Added To The Russell 3000 Index And The Small-Cap Russell 2000
08 Jun 2022 //
GLOBENEWSWIRE
Celularity Appoints Industry Leader Diane Parks to its Board of Directors
03 Jun 2022 //
GLOBENEWSWIRE
Celularity Shares Rise 8.9% After Private Placement
18 May 2022 //
MARKETWATCH
Celularity Announces $30M Private Placement Under Nasdaq Rules
18 May 2022 //
GLOBENEWSWIRE
Celularity Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
